An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes

Abstract

IMPORTANCE Certain psychiatric and immune-related disorders are reciprocal risk factors. However, the nature of these associations is unclear.OBJECTIVE To characterize the pleiotropy between psychiatric and immune-related traits, as well as risk factors of hypothesized relevance. DESIGN, SETTING, AND PARTICIPANTSThis genetic association study was conducted from July 10, 2020, to January 15, 2022. Analyses used genome-wide association (GWA) statistics related to 14 psychiatric traits; 13 immune-related phenotypes, ie, allergic, autoimmune, and inflammatory disorders; and 15 risk factors related to health-related behaviors, social determinants of health, and stress response. Genetically correlated psychiatric-immune pairs were assessed using 2-sample mendelian randomization (MR) with sensitivity analyses and multivariable adjustment for genetic associations of third variables. False discovery rate correction (Q value < .05) was applied for each analysis. EXPOSURES Genetic associations.MAIN OUTCOMES AND MEASURES Genetic correlations and MR association estimates with SEs and P values. A data-driven approach was used that did not test a priori planned hypotheses. RESULTSA total of 44 genetically correlated psychiatric-immune pairs were identified, including 31 positive correlations (most consistently involving asthma, Crohn disease, hypothyroidism, and ulcerative colitis) and 13 negative correlations (most consistently involving allergic rhinitis and type 1 diabetes). Correlations with third variables were especially strong for psychiatric phenotypes. MR identified 7 associations of psychiatric phenotypes on immune-related phenotypes that were robust to multivariable adjustment, including the positive association of (1) the psychiatric cross-disorder phenotype with asthma (odds ratio [OR], 1.04; 95% CI, 1.02-1.06), Crohn disease (OR, 1.09; 95% CI, 1.05-1.14), and ulcerative colitis (OR, 1.09; 95% CI, 1.05-1.14); (2) major depression with asthma (OR, 1.25; 95% CI, 1.13-1.37); (3) schizophrenia with Crohn disease (OR, 1.12; 95% CI, 1.05-1.18) and ulcerative colitis (OR, 1.14; 95% CI, 1.07-1.21); and a negative association of risk tolerance with allergic rhinitis (OR, 0.77; 95% CI, 0.67-0.92). CONCLUSIONS AND RELEVANCEResults of this genetic association study suggest that genetic liability for psychiatric disorders was associated with liability for several immune disorders, suggesting that vertical pleiotropy related to behavioral traits (or correlated third variables) contributes to clinical associations observed in population-scale data.

New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications

“…Interestingly, in Mendelian randomization studies focusing on immune disorders rather than biomarkers, several psychiatric disorders where found to have a causal effect on immune disorders, rather than the other direction, including a causative effect of major depressive disorder on asthma and of schizophrenia on ulcerative colitis 245 . Nonetheless, while these findings have contributed to the growing evidence base for a possible causal association between inflammatory phenotypes and psychiatric disorders, Mendelian randomization is still based on statistical inference, and it is important to control for the extensive “horizontal” pleiotropy observed between mental traits and disorders.…”

Genome‐wide association studies reveal shared genetic haplotypes of autoimmune rheumatic and endocrine diseases with psychiatric disorders

“…Several studies have shown that autoimmune diseases are associated with psychiatric diseases like depression and psychosis (Jeppesen & Benros, 2019 ). In addition, genetic evidence further supports this association (Tylee et al., 2022 ).…”

Phenome-wide genetic correlation analysis and genetically-informed causal inference of amyotrophic lateral sclerosis

“…The clumping procedure was conducted considering a p value of 10 −5 for the exposure GWAS. Similar to previous MR studies (20–23), we used this threshold to maximize the statistical power of the analyses performed. The analysis was conducted using five MR methods: inverse variance weighted (IVW), MR-Egger, simple mode, weighted median and weighted mode (24).…”